1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice


Discussion in 'Exact Sciences' started by anonymous, Sep 16, 2015 at 10:37 PM.

  1. anonymous

    anonymous Guest

    So I hit over 100% on my last quota. I busted my ass and my quota was a couple hundred kits shipped. Now it has increased 50% for the next quarter. This is ridiculous. Do they WANT us to fail?
  2. anonymous

    anonymous Guest

    In short, YES. The MDR team will take the field reps job. Our role is to generate buzz and gain new writers. Look what's happening now. There will be no need for our on the ground reps.
  3. anonymous

    anonymous Guest

    Agreed. Self-checkouts at stores, robots answering phone calls, etc.